Teodoro del Ser

20.7k total citations · 4 hit papers
98 papers, 8.3k citations indexed

About

Teodoro del Ser is a scholar working on Psychiatry and Mental health, Neurology and Physiology. According to data from OpenAlex, Teodoro del Ser has authored 98 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Psychiatry and Mental health, 25 papers in Neurology and 20 papers in Physiology. Recurrent topics in Teodoro del Ser's work include Dementia and Cognitive Impairment Research (37 papers), Alzheimer's disease research and treatments (19 papers) and Parkinson's Disease Mechanisms and Treatments (16 papers). Teodoro del Ser is often cited by papers focused on Dementia and Cognitive Impairment Research (37 papers), Alzheimer's disease research and treatments (19 papers) and Parkinson's Disease Mechanisms and Treatments (16 papers). Teodoro del Ser collaborates with scholars based in Spain, United States and United Kingdom. Teodoro del Ser's co-authors include David G. Muñoz, Marı́a Victoria Zunzunegui, À. Otero, Beatriz Alvarado, Justo Garcı́a de Yébenes, Israel Ampuero, Lídice Vidal, Janet Hoenicka, Raquel Ros and Juan Carlos Gómez‐Esteban and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Teodoro del Ser

95 papers receiving 8.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia

2003 2.1k citations Teodoro del Ser, David G. Muñoz et al. profile →
Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study

2000 744 citations Ian G. McKeith, Teodoro del Ser et al. profile →
Social Networks, Social Integration, and Social Engagement Determine Cognitive Decline in Community-Dwelling Spanish Older Adults

2003 551 citations Marı́a Victoria Zunzunegui, Teodoro del Ser et al. profile →
A Phase II Trial of Tideglusib in Alzheimer's Disease

2015 404 citations Miguel Calero, María V. Andrés et al. Journal of Alzheimer s Disease profile →

Peers

Countries citing papers authored by Teodoro del Ser

Since Specialization

Citations

This map shows the geographic impact of Teodoro del Ser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teodoro del Ser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teodoro del Ser more than expected).

Fields of papers citing papers by Teodoro del Ser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teodoro del Ser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teodoro del Ser. The network helps show where Teodoro del Ser may publish in the future.

Co-authorship network of co-authors of Teodoro del Ser

This figure shows the co-authorship network connecting the top 25 collaborators of Teodoro del Ser. A scholar is included among the top collaborators of Teodoro del Ser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teodoro del Ser. Teodoro del Ser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Oral Microbiome–Derived Proteins in Brain Extracellular Vesicles Circulate and Tie to Specific Dysbiotic and Neuropathological Profiles in Age-Related Dementias 2025 ·Molecular & Cellular Proteomics ·María Mulet, (unknown), (unknown), (unknown), (unknown), Maurício Castillo, (unknown), María‐Victoria Mateos‐Moreno, Yoshiki Hase, (unknown), Alberto Rábano, Teodoro del Ser, Raj N. Kalaria, Anna Lagunas, Mònica Mir, (unknown), Josep Samitier, Xavier Gallart‐Palau, Aida Serra	0
2	Plasma Biomarkers in the Distinction of Alzheimer’s Disease and Frontotemporal Dementia 2025 ·International Journal of Molecular Sciences ·Estrella Gómez‐Tortosa, (unknown), (unknown), (unknown), (unknown), Ignacio Mahíllo, (unknown), María José Sainz, (unknown), Teodoro del Ser, Pascual Sánchez‐Juan	1
3	Plasma Neurodegenerative Biomarkers in Cognitively Preserved Nonagenarians 2024 ·Aging and Disease ·Estrella Gómez‐Tortosa, (unknown), (unknown), (unknown), (unknown), Ignacio Mahíllo, (unknown), María José Sainz, (unknown), (unknown), Teodoro del Ser, Pascual Sánchez‐Juan	2
4	Dimensions of cognitive reserve and their predictive power of cognitive performance and decline in the elderly 2023 ·PubMed ·Teodoro del Ser, (unknown), (unknown), Marina Ávila‐Villanueva, Belén Frades, (unknown), Meritxell Valentí, Linda Zhang, Miguel A. Fernández‐Blázquez	1
5	Validez discriminante y concordancia interobservador de 2 métodos de puntuación del test del reloj 2023 ·Revista Española de Geriatría y Gerontología ·Teodoro del Ser, Belén Frades, Meritxell Valentí, María Ascensión Zea‐Sevilla, (unknown), Cristóbal Carnero Pardo	1
6	Residence, Clinical Features, and Genetic Risk Factors Associated with Symptoms of COVID-19 in a Cohort of Older People in Madrid 2021 ·Gerontology ·Teodoro del Ser, Miguel A. Fernández‐Blázquez, Meritxell Valentí, María Ascensión Zea‐Sevilla, Belén Frades, (unknown), (unknown), Olga Calero, Fernando García López, Alberto Rábano, Miguel Medina, Miguel Calero	27
7	MADRID+90 study on factors associated with longevity: Study design and preliminary data 2021 ·PLoS ONE ·Miguel A. Fernández‐Blázquez, Teodoro del Ser, Belén Frades‐Payo, Marina Ávila‐Villanueva, Meritxell Valentí, (unknown), (unknown), Eduardo J. Pedrero Pérez, (unknown), Ana Belén Pastor, (unknown), (unknown), José Manuel Díaz Olalla, Nadine Correia Santos, Fernando Maestú, Jaime Gómez‐Ramírez	6
8	Predementia constructs: Mild cognitive impairment or mild neurocognitive disorder? A narrative review 2020 ·International Journal of Geriatric Psychiatry ·Félix Bermejo‐Pareja, Israel Contador, Teodoro del Ser, Javier Olazarán, Sara Llamas‐Velasco, Saturio Vega, Julián Benito‐León	12
9	Tau phosphorylation by glycogen synthase kinase 3β modulates enzyme acetylcholinesterase expression 2020 ·Journal of Neurochemistry ·(unknown), (unknown), Jordi Alom, Teodoro del Ser, Jesús Ávila, Javier Sáez‐Valero, María‐Salud García‐Ayllón	26
10	Antiseizure medication withdrawal in seizure-free patients with PCDH19-related epilepsy: A multinational cohort survey 2020 ·Seizure ·Ángel Aledo‐Serrano, Teodoro del Ser, António Gil‐Nagel	8
11	Progression of two Progressive Supranuclear Palsy phenotypes with comparable initial disability 2019 ·Parkinsonism & Related Disorders ·Ali Shoeibi, Irene Litvan, Eduardo Tolosa, Teodoro del Ser, (unknown)	20
12	Cognitive-Motor Intervention in Alzheimer's Disease: Long-Term Results from the Maria Wolff Trial 2015 ·Journal of Alzheimer s Disease ·Rubén Múñiz, (unknown), ‌Barry Reisberg, José Manuel Casas‐Rojo, Teodoro del Ser, (unknown), Javier Olazarán	15
13	A phase 2 trial of the GSK‐3 inhibitor tideglusib in progressive supranuclear palsy 2014 ·Movement Disorders ·Eduardo Tolosa, Irene Litvan, Günter U. Höglinger, David J. Burn, Andrew J. Lees, María V. Andrés, (unknown), Teresa León, Teodoro del Ser, (unknown)	240
14	Loss of serum IGF-I input to the brain as an early biomarker of disease onset in Alzheimer mice 2013 ·Translational Psychiatry ·Ángel Trueba-Sáiz, Carmen Cavada, Ana M. Fernández, Thomas Y.Y. Leon, Débora A. González, Juan Fortea, Alberto Lleó, Teodoro del Ser, Ángel Núñez, Ignacio Torres‐Alemán	69
15	Demencia no detectada y utilización de los servicios sanitarios: implicaciones para la atención primaria 2003 ·Atención Primaria ·(unknown), Teodoro del Ser, Ángel Rodríguez‐Laso, (unknown), Julio Domingo, Ángel Otero Puime	9
16	Prestroke Dementia 2001 ·Cerebrovascular Diseases ·Raquel Barba, (unknown), (unknown), (unknown), Elena Rodríguez-García, Rafael Cantón, Teodoro del Ser	41
17	Clinical and Pathologic Features of Two Groups of Patients With Dementia With Lewy Bodies: Effect of Coexisting Alzheimer-Type Lesion Load 2001 ·Alzheimer Disease & Associated Disorders ·Teodoro del Ser, Vladimir Hachinski, Harold Merskey, David G. Muñoz	84
18	Dementia with Lewy bodies: findings from an international multicentre study 2000 ·International Journal of Geriatric Psychiatry ·Teodoro del Ser, Ian G. McKeith, Ravi Anand, A. Cicin-Sain, Roberto Ferrara, (unknown)	77
19	An autopsy-verified study of the effect of education on degenerative dementia 1999 ·Brain ·Teodoro del Ser, Vladimir Hachinski, Harold Merskey, David G. Muñoz	123
20	La depresión como factor predictor del deterioro cognitivo en las personas mayores 1999 ·Revista Española de Geriatría y Gerontología ·Marı́a Victoria Zunzunegui, François Béland, Isolde Gornemann, Teodoro del Ser	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact